Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

Based in the United Kingdom, Haleon makes consumer health care products, including Advil, Centrum Multivitamin and Aquafresh ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...

First-line treatment with targeted therapies plus chemotherapy offered overall response benefits in BRAF V600E-mutant ...

It wants to get ahead of competitors such as BMS, Merck, Pfizer, and in particular, its Swiss neighbours and cancer leaders Roche. The deal includes two recently approved GSK products for ...

(Sharecast News) - European regulators have expanded the usage of GSK's Jemperli drug for endometrial cancer, the pharmaceutical firm announced on Mon... (Alliance News) - Pfizer Inc sold 700 ...

Leading MNCs include Abbott (#1st Rank), GSK (#4th Rank) and Pfizer (includes Wyeth, #8th Rank) finding their presence among the Top 10 players in the domestic market. This also includes Daichii ...

Median duration of therapy was 20.5 months for the combination and 16.4 months with single-agent nivolumab. Median number of ...